Lilly 1Q Revenues: $5.1 billion (+3%) 1Q Earnings: $4.2 billion (earnings were $1.2 billion 1Q18) Comments: Key growth products launched since 2014, including Trulicity, Taltz, Verzenio, Basaglar, Olumiant, Jardiance, Cyramza and Emgality represented approximately 39% of revenue. Trulicity sales were $879.7 million in the quarter, up 30%. Taltz sales were up 72% to $252.5 million. Basaglar sales were $251.4 million, up 51%. Verzenio sales were $109.4 million, up from $29.7 million in 1Q18. Al...